Program in Placebo Studies

This article has multiple issues. Please help or discuss these issues on the . (Learn how and when to remove these template messages) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the . (September 2020) (Learn how and when to remove this template message) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources:  –  ·  ·  · scholar · JSTOR (September 2020) (Learn how and when to remove this template message) This article does not cite any sources. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources:  –  ·  ·  · scholar · JSTOR (September 2020) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

The Program in Placebo Studies and the Therapeutic Encounter was founded in July 2011, at Beth Israel Deaconess Medical Center and the Harvard Medical School. Its purpose is to bring together researchers who are examining the placebo response.

PiPS is led by the following members of the Harvard faculty:

• Ted Kaptchuk, Director
• Irving Kirsch, PhD, Associate Director
• Randy L. Gollub, MD, PhD, Director of Neuroimaging
• Anne Harrington, PhD, Director of Initiatives in the Humanities
• Efi Kokkoutou, MD, PhD, Director of Molecular Biology Research
• John Kelley, PhD, Director of Psychological Research
• Anthony Lembo, MD, Director of Clinical Research

External links[]

• Program in Placebo Studies and the Therapeutic Encounter website